We've received your request for NDC00409-5093-11 (described as Ceftazidime For Inj), manufactured by Hospira Inc with CAGE code 3VBU6. This part is registered under NSN 6505-01-528-6349, classified in FSG / FSC . Our verification process will confirm traceability through supporting identifiers including NIIN 01-528-6349, NCB code 01 (origin: USA), and INC 42844. Please submit your formal quotation request to proceed.
Thank you for choosing Aerospace Exchange for your NDC00409-5093-11 requirements. We specialize in authenticated aerospace components, offering both NSN-tracked military parts and commercial equivalents, all validated through our rigorous sourcing protocols.
How to Begin the Quotation Process
| NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
|---|---|---|---|---|---|---|
| 6505-01-528-6349 Item PartTypeName: CEFTAZIDIME FOR INJECTION | 6505 | 015286349 | M | P | ||
| CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
| U | A | |||||
| Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
| 05-0144 | 2 | 1 | 5 |
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CSGS | ADMINISTRATION | INTRAVENOUS |
| FEAT | SPECIAL FEATURES | STORE IN A DRY STATE, BETWEEN 15 AND 30 DEG. C; PROTECT FROM LIGHT; FOR IV USE; TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; TRAY OF 10S |
| AJUC | AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 81206 |
| SUPP | SUPPLEMENTARY FEATURES | ADDVANTAGE VIALS TO BE USED WITH ADDVANTAGE DILUENT |
| AGXW | PHYSICAL FORM | POWDER |
| CBBL | FEATURES PROVIDED | STERILE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 18.000 MILLILITERS AFTER RECONSTITUTION |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTAZIDIME F/INJ 2GM ADD-VANTAGE VIAL, 10'S |
| End Use : 40100 | Pharmaceutical preparations |
|---|---|
| Schedule B : 3004909140 (NAICS 325412) | Medicaments primarily affecting the central nervous system, put up in measured doses or in forms or packings for retail sale, nesoi |
| SITC : 54293 | Medicaments, n.E.S., in dosage form or retail packings |
| CRITL | The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. |
|---|---|
| HMIC | P - Indicates there is no information in the hmirs. The nsn is in a fsc in table ii of federal standard 313 and a msds may be required by the user. The requirement for a msds is dependent on a hazard determination of the supplier or the intended end use of item. |
| PMIC | A - Item does not contain precious metal. |
| AAC | L |
|---|---|
| Classification Control | U |
| MGMT_CTL | C2201x- |
| Quantity per pack | 1 |
| Repariability | |
| Shelf Life | 24 mo. |
| SOS | Sms |
| Unit of Measure | Pg |
 |
AS9120B and ISO 9001:2015 |
 |
Aviation Suppliers Association Member |
 |
FAA AC 0056B Accredited |
 |
AS 6081:2012 Certification |
 |
ESD S20.20-2014 Certification |
Don’t forget That We offer 24/7 Service, Competitive Prices, and Fast Deliveries. We Hope You'll Make Us Your One-Stop Purchasing Solution!
Request for Quote
